3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
20
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Ovarian Neoplasms
29
Uterine Cervical Neoplasms
23
Endometrial Neoplasms
14
Breast Neoplasms
10
Neoplasms
8
Uterine Cervical Dysplasia
5
Carcinoma, Ovarian Epithelial
5
Peritoneal Neoplasms
4
Papillomavirus Infections
4
Lung Neoplasms
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Pancreatic Neoplasms
3
Neoplastic Cells, Circulating
3
Hereditary Breast and Ovarian Cancer Syndrome
3
Disease
3
Uterine Neoplasms
2
Prostatic Neoplasms
2
Primary Ovarian Insufficiency
2
Ovarian Diseases
2
Melanoma
2
Leukemia
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Hyperplasia
2
Vulvar Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Interventions
pembrolizumab
20
Nivolumab
10
Cyclophosphamide
10
atezolizumab
6
Specimen Handling
6
fludarabine
5
Magnetic Resonance Spectroscopy
5
cabozantinib
4
Ipilimumab
4
Bevacizumab
4
lenvatinib
3
X-Rays
3
Trastuzumab
3
Paclitaxel
3
Oxaliplatin
3
Immunoglobulin G
3
Fluorodeoxyglucose F18
3
ulixertinib
2
sargramostim
2
poly ICLC
2
epacadostat
2
enzalutamide
2
durvalumab
2
cemiplimab
2
budigalimab
2
avelumab
2
aldesleukin
2
aflibercept
2
Sirolimus
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Blood Specimen Collection
×
Gynecologic
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled